Carta al editor “Colestasis intrahepática por Treponema pallidum en paciente inmunocompetente”
Downloads
References
Orozco-Sebá BE, Viasus D, Meléndez E, Fuentes J, Tovar J, Amado EA, et al. Colestasis intrahepática por Treponema pallidum en paciente inmunocompetente. Biomedica.
;43:164-70.
University of Oxford. A phase-I dose-escalation study to evaluate the safety and immunogenicity of prime-boost immunizations with candidate HCV vaccines, ChAd3-
hliNSMut and MVA-hliNSMut in healthy volunteers and patients previously chronically infected with HCV [Internet]. Clinicaltrials.gov. 2023. Report No.: NCT03688061. Fecha de consulta: 31 de diciembre de 2022. Disponible en: https://clinicaltrials.gov/study/NCT03688061
National Institute of Allergy and Infectious Diseases (NIAID). A staged phase I/II study, to assess safety, efficacy and immunogenicity of a new hepatitis C prophylactic vaccine based on sequential use of AdCh3NSmut1 and MVA-NSmut. Clinicaltrials.gov. 2019. Report No.: NCT01436357. Fecha de consulta: 31 de diciembre de 2022. Disponible en: https://clinicaltrials.gov/study/NCT01436357
Some similar items:
- Beatriz E. Orozco-Sebá, Diego Viasus, Esperanza Meléndez, Jairo Fuentes, José Tovar, Elkin A. Amado, Daniela Loaiza, Amendment. Intrahepatic cholestasis due to Treponema pallidum in an immunocompetent patient , Biomedica: Vol. 44 No. 2 (2024)
Copyright (c) 2024 Biomedica
This work is licensed under a Creative Commons Attribution 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
